by Eric Christianson | Apr 12, 2023 | Endocrine Medication and Disease State Clinical Pearls
It is theorized that patients who are taking a GLP-1 agonist are at a greater risk for pancreatitis due to the medication causing an increase in stimulation of GLP-1 receptors located in the pancreas. This could lead to an overgrowth or overactivation of pancreatic...
by Eric Christianson | Apr 9, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Bempedoic acid, also known as Nexletol, is a once-daily medication used in patients with increased atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia who are requiring additional LDL-C lowering previously on a maximally...
by Eric Christianson | Apr 5, 2023 | Uncategorized
We have had a wonderful response to our previous pharmacology crossword on diabetes so I figured I try this again. With the help of a pharmacy student, Cody Springer, we have created a free heart failure pharmacology crossword puzzle! I know some folks out there...
by Eric Christianson | Apr 2, 2023 | Polypharmacy Cases And The Prescribing Cascade
Polypharmacy is something I’m extremely passionate about. In my work as a consultant pharmacist, there isn’t a much better feeling for me than eliminating medications that the patient doesn’t need. To successfully minimize polypharmacy (check out my...
by Eric Christianson | Mar 29, 2023 | Infectious Disease and Oncology Case Studies, Neurology, Pain, and Musculoskeletal Case Studies
I stumbled into this case about Valtrex neurotoxicity on Linked In, and am so thankful that Kristin Speer, PharmD, BCPS let me share it. A physician attached a message for the care team to review: “Patient continues with dizziness, hallucinations, and...
